Bimosiamose
Bimosiamose has anti-inflammatory effects[1]. Bimosiamose (TBC-1269) is a nonoligosaccharide pan-selectin antagonist with IC50s of 88 μM, 20 μM, and 86 μM for E-selectin, L-selectin, and P-selectin respectively.
| Catalog Number | T14574 |
| Alternative Name(s) | TBC-1269 |
| Research Area | Cytoskeletal Signaling |
| Molecular Formula | C46H54O16 |
| CAS# | 187269-40-5 |
| SMILES | O(C1=C(C=C(CCCCCCC2=CC(=C(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)C=C2)C4=CC(CC(O)=O)=CC=C4)C=C1)C5=CC(CC(O)=O)=CC=C5)[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Bimosiamose |
| Additional Information | https://www.targetmol.com/datasheet/T14574 |